MedPath

Evaluation of adding Vitix gel on vitiligo lesions treating with NB-UVB phototherapy in patients referring to dermatology clinic of Quaem hospital

Phase 2
Conditions
Vitiligo.
Vitiligo
Registration Number
IRCT2015011216955N2
Lead Sponsor
Vice Chancellor for Research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Bilateral symmetrical lesions distributed on face or limbs that involving more than 10% of body surface; age>12 years; who had signed a written informed consent.
exclusion criteria: pregnancy; breast feeding; any history of previous hypersensitivity to Vitix gel; having skin malignancy; history of immunosuppression or taking immunosuppressive drugs; any contraindications for phototherapy; previous treatment with phototherapy from 3 months ago; history of photosensitivity; history of psychologic disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion improvement based on amount of repigmentation. Timepoint: Monthly for 4 months. Method of measurement: Calculation the repigmentation score according to a certain classification.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Monthly. Method of measurement: Based on history, physical examination and observation of the patient.
© Copyright 2025. All Rights Reserved by MedPath